Ixiaro vaccine receives Marketing Authorization in Europe for the prevention of Japanese Encephalitis
Links shared publicly online about this topic.
- 2,145total visits
Ixiaro vaccine receives Marketing Authorization in Europe for the prevention of Japanese Encephalitis
Basel, April 2, 2009 - The European Commission has granted Marketing Authorization to Ixiaro vaccine for the prevention of Japanese Encephalitis (JE). JE, a mosquito-borne flaviviral infection, results in 10,000-15,000 deaths annually[1],[2] and is a potentially life-threatening disease for travelers to Asia.
View full resource at novartis.com
Tags: Vaccination, Infection, Encephalitis, Disease and Condition, Vaccine
Most Recently Shared on April 2, 2009 at 4:30 pm By:
Ixiaro® vaccine receives Marketing Authorization in Europe for the prevention of Japanese Encephalitis: http://twurl.nl/8istd4
Advertisement
